Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04050748 · ClinicalTrials.gov registry record · NA
Achilles Tendon Lengthening With Traditional vs. Accelerated Rehab
A NA study of Achilles Tendon Rupture, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT04050748: Completed NA study of Achilles Tendon Rupture, sponsored by Henry Ford Health System.
NCT04050748 is a NA study of Achilles Tendon Rupture that has completed, run by Henry Ford Health System. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04050748, a NA study of Achilles Tendon Rupture, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the surgically repaired tendon of a ruptured achilles tendon. We will investigate fixation slippage and tendon creep and correlate how these post-repair findings can contribute to outcomes of tendon repairs.
Primary Outcome
Intratendinous and repair site lengthening were determined
Conditions Studied
Interventions
- PROCEDURE Achilles tendon repair
Study Locations (1)
Michigan
- Health Ford Health System - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2019-06-05 |
| Phase | NA |
What the finished NCT04050748 record still lists
NCT04050748 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Achilles Tendon Rupture appearing as the primary indexed condition, and to 1 intervention - of which Achilles tendon repair is the first listed.
NCT04050748 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04050748 about?
NCT04050748 is a clinical study titled "Achilles Tendon Lengthening With Traditional vs. Accelerated Rehab". The purpose of this study is to evaluate the surgically repaired tendon of a ruptured achilles tendon. We will investigate fixation slippage and tendon creep and correlate how these post-repair findings can contribute to outcomes of tendon repairs.
What is the current status of trial NCT04050748?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-06-01. Estimated completion is 2019-06-05.
What conditions does trial NCT04050748 study?
This clinical trial studies the following conditions: Achilles Tendon Rupture.
What interventions are being tested in trial NCT04050748?
The interventions under investigation include: Achilles tendon repair (PROCEDURE).
Who is sponsoring clinical trial NCT04050748?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04050748 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Achilles Tendon Rupture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04050748's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI